Abstract SP112: Spatial variance signatures/Intra-tumor zonation in TNBC

Autor: Alexis Blanchet-Cohen, C. Martinez Ramirez, Jiannis Ragoussis, Paul Savage, Hellen Kuasne, Yingchao Yang, Claudia L. Kleinman, Sarkis Meterissian, A Omeroglou, Anne-Marie Fortier, Santiago Costantino, Morag Park

Publikováno v: Cancer Research. 81:SP112-SP112

It is increasingly clear that triple negative breast cancer (TNBC) is a heterogeneous disease with variable clinical presentation, histological features and response to therapy. While these differences have been partially explained by inter- and intr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::958c119e2b82d955c15f191845273c41
https://doi.org/10.1158/1538-7445.sabcs20-sp112

Coordinated activation of c-Src and FOXM1 drives tumor cell proliferation and breast cancer progression.

Autor: Nandi I; Rosalind and Morris Goodman Cancer Institute and.; Department of Biochemistry, McGill University, Montreal, Quebec, Canada., Smith HW; Rosalind and Morris Goodman Cancer Institute and., Sanguin-Gendreau V; Rosalind and Morris Goodman Cancer Institute and.; Department of Biochemistry, McGill University, Montreal, Quebec, Canada., Ji L; Rosalind and Morris Goodman Cancer Institute and., Pacis A; Rosalind and Morris Goodman Cancer Institute and.; Canadian Centre for Computational Genomics, McGill Genome Centre, Montreal, Quebec, Canada., Papavasiliou V; Rosalind and Morris Goodman Cancer Institute and.; Department of Biochemistry, McGill University, Montreal, Quebec, Canada., Zuo D; Rosalind and Morris Goodman Cancer Institute and.; Department of Biochemistry, McGill University, Montreal, Quebec, Canada., Nam S; Rosalind and Morris Goodman Cancer Institute and., Attalla SS; Rosalind and Morris Goodman Cancer Institute and.; Department of Biochemistry, McGill University, Montreal, Quebec, Canada., Kim SH; Department of Chemistry, University of Illinois at Urbana-Champaign, Champaign, Illinois, USA., Lusson S; Rosalind and Morris Goodman Cancer Institute and.; Department of Biochemistry, McGill University, Montreal, Quebec, Canada., Kuasne H; Rosalind and Morris Goodman Cancer Institute and., Fortier AM; Rosalind and Morris Goodman Cancer Institute and., Savage P; Rosalind and Morris Goodman Cancer Institute and.; Department of Surgery, University of Toronto, Toronto, Ontario, Canada., Martinez Ramirez C; Rosalind and Morris Goodman Cancer Institute and.; Department of Medicine and., Park M; Rosalind and Morris Goodman Cancer Institute and.; Department of Biochemistry, McGill University, Montreal, Quebec, Canada.; Department of Medicine and.; Department of Oncology, McGill University, Montreal, Quebec, Canada., Katzenellenbogen JA; Department of Chemistry and Cancer Center and., Katzenellenbogen BS; Department of Molecular and Integrative Physiology, Cancer Center and Institute for Genomic Biology, University of Illinois and College of Medicine at Urbana-Champaign, Champaign, Illinois, USA., Muller WJ; Rosalind and Morris Goodman Cancer Institute and.; Department of Biochemistry, McGill University, Montreal, Quebec, Canada.

Publikováno v: The Journal of clinical investigation [J Clin Invest] 2023 Apr 03; Vol. 133 (7). Date of Electronic Publication: 2023 Apr 03.